Retractable Technologies Inc (RVP) - Total Assets
Based on the latest financial reports, Retractable Technologies Inc (RVP) holds total assets worth $142.63 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Retractable Technologies Inc - Total Assets Trend (2000–2025)
This chart illustrates how Retractable Technologies Inc's total assets have evolved over time, based on quarterly financial data. Also see RVP company net worth for the company's overall valuation and market capitalisation.
Retractable Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Retractable Technologies Inc's total assets of $142.63 Million consist of 44.2% current assets and 55.8% non-current assets. Review RVP total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.59 Million | 1.8% |
| Accounts Receivable | $8.21 Million | 5.8% |
| Inventory | $17.19 Million | 12.1% |
| Property, Plant & Equipment | $79.49 Million | 55.7% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Retractable Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Retractable Technologies Inc stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Retractable Technologies Inc's current assets represent 44.2% of total assets in 2025, an increase from 39.3% in 2000.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2025, down from 18.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2000.
- Asset Diversification: The largest asset category is property, plant & equipment at 55.7% of total assets.
Retractable Technologies Inc Competitors by Total Assets
Key competitors of Retractable Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Retractable Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.57 | 8.34 | 2.47 |
| Quick Ratio | 4.78 | 6.16 | 2.22 |
| Cash Ratio | 0.27 | 0.48 | 0.00 |
| Working Capital | $53.49 Million | $64.49 Million | $52.79 Million |
Retractable Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Retractable Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.26 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -11.3% |
| Total Assets | $142.63 Million |
| Market Capitalization | $20.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values Retractable Technologies Inc's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Retractable Technologies Inc's assets decreased by 11.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Retractable Technologies Inc (2000–2025)
The table below shows the annual total assets of Retractable Technologies Inc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $142.63 Million | -11.26% |
| 2024-12-31 | $160.72 Million | -10.55% |
| 2023-12-31 | $179.67 Million | -14.74% |
| 2022-12-31 | $210.74 Million | -1.13% |
| 2021-12-31 | $213.15 Million | +103.06% |
| 2020-12-31 | $104.97 Million | +129.02% |
| 2019-12-31 | $45.84 Million | +24.58% |
| 2018-12-31 | $36.79 Million | -3.57% |
| 2017-12-31 | $38.16 Million | -1.61% |
| 2016-12-31 | $38.78 Million | -8.84% |
| 2015-12-31 | $42.54 Million | -6.20% |
| 2014-12-31 | $45.35 Million | -7.63% |
| 2013-12-31 | $49.10 Million | +3.08% |
| 2012-12-31 | $47.63 Million | -2.32% |
| 2011-12-31 | $48.76 Million | -8.33% |
| 2010-12-31 | $53.19 Million | -1.39% |
| 2009-12-31 | $53.94 Million | -7.85% |
| 2008-12-31 | $58.54 Million | -9.00% |
| 2007-12-31 | $64.33 Million | -9.13% |
| 2006-12-31 | $70.79 Million | -4.01% |
| 2005-12-31 | $73.76 Million | -3.58% |
| 2004-12-31 | $76.49 Million | +223.71% |
| 2003-12-31 | $23.63 Million | +30.85% |
| 2002-12-31 | $18.06 Million | -2.60% |
| 2001-12-31 | $18.54 Million | -9.51% |
| 2000-12-31 | $20.49 Million | -- |
About Retractable Technologies Inc
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more